AKASA
PrivateLast Round
Early Funding
Jun 18, 2024
Est. Valuation
$94.43M
Total Funding Raised
$325M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AKASA is a healthcare technology company that provides generative AI solutions to streamline revenue cycle management for health systems.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Healthcare Analytics, Workflow Automation, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AKASA Comparables
Compare AKASA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adonis | 87% | |
| Janus Health | 86% | |
| Arintra | 85% |
AKASA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 18, 2024 | ||||
| Series B | Mar 23, 2021 | ||||
| Series A | Jun 10, 2020 | ||||
| Seed | Dec 20, 2018 |
Key People
Founding team and executive leadership
AKASA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Early Funding, Series C, Series B, Seed, Series A |
| Bond Capital | Series B |
| Costanoa Ventures | Early Funding, Seed, Series C, Series B, Series A |
| Coatue Management | Series C |
| BOND | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 22, 2026
CEO ranked among Top 50 Healthcare Technology CEOs.
- Mar 22, 2026
Certified for 6 consecutive years.
AKASA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AKASA's valuation, stock price, and market status.
Is AKASA a public or private company?
AKASA is a private company.
What is the current stock price of AKASA?
AKASA is a private company with no public stock price. No recent secondary market data is available.
How much is AKASA worth (valuation)?
Valuation information for AKASA is not publicly available.
Can I buy AKASA stock?
AKASA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AKASA's last funding round?
AKASA's most recent funding round was Early Funding on June 18, 2024.
Who are the main investors in AKASA?
Key investors in AKASA include Andreessen Horowitz, Bond Capital, BOND.
Will AKASA IPO soon?
No public IPO plans have been announced for AKASA.
How can I track AKASA secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AKASA's secondary market activity and sign up for updates.